Topic Review
CD123 in Blastic Plasmacytoid Dendritic Cell Neoplasm
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare and aggressive hematologic cancer originating from the malignant transformation of plasmacytoid dendritic cell precursors. The exploration of combinations such as CD123-targeted immunotherapies with azacitidine and venetoclax is suggested to enhance antineoplastic responses and improve survival rates in BPDCN patients.
  • 207
  • 30 Jan 2024
Topic Review
Immune Responses Potentially Involved in Brucella-Induced Pregnancy Complications
Infection by Brucella species in pregnant animals and humans is associated with an increased risk of abortion, preterm birth, and transmission of the infection to the offspring. The pathogen has a marked tropism for the placenta and the pregnant uterus and has the ability to invade and replicate within cells of the maternal–fetal unit, including trophoblasts and decidual cells. Placentitis is a common finding in infected pregnant animals. Several proinflammatory factors have been found to be increased in both the placenta of Brucella-infected animals and in trophoblasts or decidual cells infected in vitro. As normal pregnancies require an anti-inflammatory placental environment during most of the gestational period, Brucella-induced placentitis is thought to be associated with the obstetric complications of brucellosis.
  • 206
  • 22 Jan 2024
Topic Review
Anakinra Therapy for Deficiency of Interleukin-1 Receptor Antagonist
Deficiency of interleukin-1 receptor antagonist (DIRA) is a rare life-threatening autosomal recessive autoinflammatory disease with symptoms including but not limited to osteomyelitis, periostitis, and systemic inflammation. DIRA is developed from the loss-of-function biallelic mutations of the IL1RN gene that encodes IL-1 receptor antagonist (IL-1RA), leading to the unchecked pro-inflammatory signaling and subsequent systemic inflammation. 
  • 201
  • 01 Mar 2024
Topic Review
Mesenchymal Stromal Cells from Dental and Periodontal Tissues
Mesenchymal stem/stromal cells (MSCs) are multipotent cells located in different areas of the human body. The oral cavity is considered a potential source of MSCs because they have been identified in several dental tissues (D-MSCs). Clinical trials in which cells from these sources were used have shown that they are effective and safe as treatments for tissue regeneration. Importantly, immunoregulatory capacity has been observed in all of these populations. Since this property is of clinical interest for cell therapy protocols, it is relevant to analyze the differences in immunoregulatory capacity, as well as the mechanisms used by each type of MSC. Interestingly, D-MSCs are the most suitable source for regenerating mineralized tissues in the oral region. Furthermore, the clinical potential of D-MSCs is supported due to their adequate capacity for proliferation, migration, and differentiation. There is also evidence for their potential application in protocols against autoimmune diseases and other inflammatory conditions due to their immunosuppressive capacity.
  • 197
  • 11 Mar 2024
Topic Review
Combination Immunotherapiess for Renal cell carcinoma
Renal cell carcinoma (RCC) constitutes a considerable burden on public health, with an estimated 81,800 new diagnoses and 14,890 mortality cases predicted for 2023 in the United States alone. Over the recent years, the incidence of RCC has exhibited a consistent upward trend. Among the various subtypes, clear cell renal cell carcinoma (ccRCC) predominates, accounting for approximately 70–80% of RCC cases, with the majority originating from the proximal convoluted tubule. Conversely, the non-clear cell renal cell carcinomas (nccRCCs), encompassing entities such as papillary, chromophobe, translocation, and medullary RCC, as well as collecting duct carcinoma, comprise 20–30% of RCC and harbor distinct histopathological and molecular characteristics.
  • 196
  • 03 Jan 2024
Topic Review
Varied Microbiome Profiles in Neonates
The field of human microbiome and gut microbial diversity research has witnessed a profound transformation, driven by advances in omics technologies. These advancements have unveiled essential connections between microbiome alterations and severe conditions, prompting the development of new frameworks through epidemiological studies. Traditionally, it was believed that each individual harbored unique microbial communities acquired early in life, evolving over the course of their lifetime, with little acknowledgment of any prenatal microbial development, but research challenges this belief. The neonatal microbiome’s onset, influenced by factors like delivery mode and maternal health, remains a subject of intense debate, hinting at potential intrauterine microbial processes. 
  • 196
  • 05 Jan 2024
Topic Review
Interconnection between Inflammation, Epigenetics and Nutrition in Cancer
Inflammation is a key contributor to both the initiation and progression of tumors, and it can be triggered by genetic instability within tumors, as well as by lifestyle and dietary factors. The inflammatory response plays a critical role in the genetic and epigenetic reprogramming of tumor cells, as well as in the cells that comprise the tumor microenvironment. Cells in the microenvironment acquire a phenotype that promotes immune evasion, progression, and metastasis.
  • 192
  • 07 Mar 2024
Topic Review
Emerging Therapies and Therapeutics for Atopic Dermatitis
Atopic dermatitis (AD) is an inflammatory skin condition that frequently develops before the onset of allergic rhinitis or asthma. More than 10% of children are affected by this serious skin condition, which is painful for the sufferers. Recent research has connected the environment, genetics, the skin barrier, drugs, psychological factors, and the immune system to the onset and severity of AD. The causes and consequences of AD and its cellular and molecular origins are reviewed in this paper. The exploration of interleukins and their influence on the immunological pathway in AD has been facilitated by using relevant biomarkers in clinical trials.
  • 180
  • 02 Apr 2024
Topic Review
HIV Vaccine Development Based on Tat
Vaccination is undoubtedly the most cost-effective intervention to curb the HIV pandemic, both in the preventative and therapeutic setting. Based on the epidemiological evidence and experimental data indicating a protective role for anti-Tat immunity, in particular of anti-Tat Abs, the development of vaccines based on Tat was undertaken.
  • 176
  • 22 Feb 2024
Topic Review
The Host Response to Coccidioidomycosis
Coccidioidomycosis is an important fungal disease that is found in many desert regions of the western hemisphere.
  • 175
  • 07 Mar 2024
Topic Review
Host Immune Responses to Clostridioides difficile Infection
Clostridioides difficile infection (CDI) is a leading nosocomial infection, posing a substantial public health challenge within the United States and globally. C. difficile releases toxins, which damage large intestinal epithelium, leading to toxic megacolon, sepsis, and even death.
  • 160
  • 07 Feb 2024
  • Page
  • of
  • 39
ScholarVision Creations